Abstract Thermal therapy for heart failure is recognized to improve clinical symptoms. We describe our experience with appendicular thermal therapy applied to a patient fitted with an extracorporeal left ventricular assist device (LVAD) who was wait-listed for a heart transplant. A 21-year-old male with end-stage heart failure due to dilated cardiomyopathy was fitted with a LVAD. His general condition stabilized after LVAD placement and the status of his heart failure has remained at NYHA class II for the past 13 months. However, his cardiac function did not sufficiently recover to discontinue LVAD support. We conducted appendicular thermal therapy using a steam foot bath and heated gloves for 2 weeks. Immediately after thermal * Corresponding author. Tel.: +81 6 6833 50121; fax: +81 6 6872 7485. E-mail address: kkoma@hsp.ncvc.go.jp (K. Komamura). therapy, his average sublingual temperature increased from 36.3 to 37.0
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Introduction
Previous studies have demonstrated the safety and efficacy of systemic thermal therapy for patients with chronic heart failure (CHF) [1] [2] [3] [4] [5] . A large number of patients in Japan have been implanted with a left ventricular assist device (LVAD) because of prolonged waits for heart transplants [6] . Although we wished to apply sauna thermal therapy to patients with LVAD, we do not have an appropriate sauna facility. Thus, we attempted to apply appendicular thermal therapy to a patient with LVAD awaiting a heart transplant. We describe for the first time the safety and effectiveness of this strategy for a patient with end-stage heart failure.
Case report
A 21-year-old man with dilated cardiomyopathy refractory to maximal medical therapy was admitted to our hospital in April 2006. Regardless of intensive care with intravenous inotropic agents, his heart failure rapidly progressed to cardiogenic shock. He was fitted with an extracorporeal LVAD (VCT-50; Toyobo Ltd., Osaka, Japan) 1 week after admission. His general condition stabilized thereafter and the status of heart failure at that time was NYHA class II. Although this status remained stable for 6 months, his cardiac function did not sufficiently recover to discontinue LVAD support. He has remained stable in NYHA class II for 13 months with the LVAD. The patient provided written informed consent to enter into a clinical trial of appendicular thermal therapy for patients with LVAD awaiting for a heart transplant. The Ethics Committee at the National Cardiovascular Center approved the protocol, and the study was conducted in accordance with the Declaration of Helsinki. The study consisted of clinical examinations before and after daily thermal therapy for 2 weeks using a steam bath at 42 • C for the lower legs and feet, and heated gloves at the same temperature for both arms (Fig. 1 ). After 15 min of therapy at 42 • C, the patient remained seated in the steam bath with the lower legs and feet wrapped with a blanket for 30 min. The procedure was accompanied by electrocardiographic monitoring. The patient remained on the following medications throughout the study period: beta-blocker (carvedilol 22.5 mg), angiotensin-converting enzyme inhibitor (enalapril 2.5 mg), diuretic (furosemide 20 mg), aldosterone antagonist (spironolactone 50 mg), antiarrhythmic (amiodarone 100 mg), anticoagulant (warfarin 3.5 mg), and antiplatelet drugs (aspirin 100 mg).
The patient's sublingual temperature immediately after 15 min of therapy increased from 36.3 ± 0.31 to 37.0 ± 0.37 • C (P < 0.0001; paired 
t-test).
His blood pressure and heart rate did not significantly differ before and after the thermal therapy (Table 1 ). The cardiothoracic ratio decreased from 60.3 to 58.6% ( Fig. 2A) . Echocardiography revealed that left atrial diameter and the grade of mitral regurgitation decreased ( Fig. 2B and C), and that LV ejection fraction increased after the therapy (Table 1) . Whereas the level of plasma BNP changed only slightly after therapy, those of plasma NTproBNP and norepinephrine decreased. Diacron reactive oxygen metabolites (dROM) in serum, which comprise a marker of oxidative stress [7] , decreased and the OXY absorbent test, a marker of anti-oxidative potency [8] , increased after the therapy (Table 1) . Serum concentrations of nitrite and nitrate, which are stable derivatives of nitric oxide, increased after therapy. We also estimated endothelial function with reactive hyperemia peripheral arterial tonometry (RH-PAT) using a fingertip arterial tonometry device (Endo-PAT; Itamar, Caesarea, Israel) [9] . Briefly, the hyperemic response after 5-min forearm cuff inflation was assessed as the log of the ratio of the post-deflation to baseline pulse amplitude in the hyperemic finger normalized to the contralateral finger (log PAT ratio). The log PAT ratio, a measure of endothelial function, doubled after therapy (Table 1) . Moreover, the patient required less time for a 300-m walk after therapy (Table 1) . 
Discussion
This is the first report of appendicular thermal therapy being applied to a patient implanted with an LVAD and awaiting a heart transplant. Whole body sauna therapy for CHF is widely recognized to include improved clinical symptoms, cardiac function, quality of life, and ventricular arrhythmia, and decreased levels of abnormally activated neurohumoral factors [1] [2] [3] [4] [5] . However, whole body sauna therapy is impractical for patients with CHF in general hospitals that lack specialized sauna facilities, whereas appendicular thermal therapy using a steam bath and heated gloves can be applied routinely within patients' rooms.
Increases in deep body temperature of 1.0-1.2 • C during sauna therapy dilate systemic arteries and veins, and reduce systemic preload and afterload, resulting in increased cardiac output [1] [2] [3] [4] [5] . The sublingual temperature of our patient after the therapy increased by about 0.7 • C. Nevertheless, the benefits seemed to be similar to those of sauna therapy. Ikeda et al. found that repeated sauna therapy increases endothelial nitric oxide synthase expression and nitric oxide production, and improves cardiac function in animal models of heart failure [10, 11] . Serum nitrite and nitrate levels doubled in our patient compared with the baseline values, as did the index of endothelial function determined by RH-PAT.
Patients implanted with an LVAD for long periods often develop serious hemorrhage in the cerebrum or elsewhere and drive-line infection. We were concerned that the therapy would aggravate hemorrhage or infection of patients through its vasodilatory effects. However, we found that oozing of blood at the insertion site of the LVAD drive-line tended to resolve during therapy.
Sauna thermal therapy attenuates psychological stress [4] . Because of a donor shortage in Japan, patients must remain attached to an LVAD and stay for over 2 years in hospital while waiting for a heart transplant [12] . The decrease in plasma norepinephrine indicated that appendicular thermal therapy also might attenuate psychological, as well as physical stress.
Conclusion
Appendicular thermal therapy was safe for this patient with an extracorporeal LVAD waiting for a heart transplant and the procedure might benefit other patients, including those with end-stage heart failure.
